Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis
CONCLUSIONS: Patients with T2DM and atherosclerosis are at high risk of limb events. Ticagrelor decreased this risk, but increased bleeding. Future trials evaluating the combination of ticagrelor and aspirin would further elucidate the benefit/risk of such therapy in patients with PAD, including those without coronary artery disease. (A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus [THEMIS]: NCT01991795).PMID:38658101 | DOI:10.1016/j.jacc.2024.03.377 (Source: Atherosclerosis)
Source: Atherosclerosis - April 24, 2024 Category: Cardiology Authors: Marc P Bonaca Deepak L Bhatt Tabassome Simon Kim Michael Fox Shamir Mehta Robert A Harrington Lawrence A Leiter Warren H Capell Claes Held Anders Himmelmann Wilhelm Ridderstr åle Jersey Chen Jane J Lee Yang Song Marielle Andersson Jayne Prats Mikhail Kos Source Type: research
The Association of CHADS-P2A2RC Risk Score With Clinical Outcomes in Patients Taking P2Y12 Inhibitor Monotherapy After 3 Months of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention
CONCLUSIONS: The CHADS-P2A2RC risk score is valuable in discriminating high-ischemic-risk patients. Even in such patients with a high risk of ischemic events, P2Y12 inhibitor monotherapy was associated with a lower incidence of bleeding without increased risk of ischemic events compared with prolonged DAPT.TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02079194.PMID:38654565 | DOI:10.4070/kcj.2023.0268 (Source: Korean Circulation Journal)
Source: Korean Circulation Journal - April 24, 2024 Category: Cardiology Authors: Pil Sang Song Seok-Woo Seong Ji-Yeon Kim Soo Yeon An Mi Joo Kim Kye Taek Ahn Seon-Ah Jin Jin-Ok Jeong Jeong Hoon Yang Joo-Yong Hahn Hyeon-Cheol Gwon Woo Jin Jang Hyuck Jun Yoon Jang-Whan Bae Woong Gil Choi Young Bin Song Source Type: research
Antiplatelet therapy for treatment of coronary artery disease in older patients
Arch Cardiovasc Dis. 2024 Apr 12:S1875-2136(24)00055-X. doi: 10.1016/j.acvd.2024.02.008. Online ahead of print.ABSTRACTCoronary artery disease in older patients is more frequently diffuse and complex, and is often treated by percutaneous coronary intervention on top of medical therapy. There are currently no specific recommendations for antiplatelet therapy in patients aged≥75 years. Aspirin remains pivotal, and is still indicated as a long-term treatment after percutaneous coronary intervention. In addition, a P2Y12 inhibitor is administered for 6-12 months according to clinical presentation. Age is a minor bleeding ris...
Source: Archives of Cardiovascular Diseases - April 24, 2024 Category: Cardiology Authors: Quentin Fischer Vincent Pham Gabriel Seret Pierre Brami Fabien Picard Olivier Varenne Source Type: research
The Association of CHADS-P2A2RC Risk Score With Clinical Outcomes in Patients Taking P2Y12 Inhibitor Monotherapy After 3 Months of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention
CONCLUSIONS: The CHADS-P2A2RC risk score is valuable in discriminating high-ischemic-risk patients. Even in such patients with a high risk of ischemic events, P2Y12 inhibitor monotherapy was associated with a lower incidence of bleeding without increased risk of ischemic events compared with prolonged DAPT.TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02079194.PMID:38654565 | DOI:10.4070/kcj.2023.0268 (Source: Korean Circulation Journal)
Source: Korean Circulation Journal - April 24, 2024 Category: Cardiology Authors: Pil Sang Song Seok-Woo Seong Ji-Yeon Kim Soo Yeon An Mi Joo Kim Kye Taek Ahn Seon-Ah Jin Jin-Ok Jeong Jeong Hoon Yang Joo-Yong Hahn Hyeon-Cheol Gwon Woo Jin Jang Hyuck Jun Yoon Jang-Whan Bae Woong Gil Choi Young Bin Song Source Type: research
Antiplatelet therapy for treatment of coronary artery disease in older patients
Arch Cardiovasc Dis. 2024 Apr 12:S1875-2136(24)00055-X. doi: 10.1016/j.acvd.2024.02.008. Online ahead of print.ABSTRACTCoronary artery disease in older patients is more frequently diffuse and complex, and is often treated by percutaneous coronary intervention on top of medical therapy. There are currently no specific recommendations for antiplatelet therapy in patients aged≥75 years. Aspirin remains pivotal, and is still indicated as a long-term treatment after percutaneous coronary intervention. In addition, a P2Y12 inhibitor is administered for 6-12 months according to clinical presentation. Age is a minor bleeding ris...
Source: Archives of Cardiovascular Diseases - April 24, 2024 Category: Cardiology Authors: Quentin Fischer Vincent Pham Gabriel Seret Pierre Brami Fabien Picard Olivier Varenne Source Type: research
The Association of CHADS-P2A2RC Risk Score With Clinical Outcomes in Patients Taking P2Y12 Inhibitor Monotherapy After 3 Months of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention
CONCLUSIONS: The CHADS-P2A2RC risk score is valuable in discriminating high-ischemic-risk patients. Even in such patients with a high risk of ischemic events, P2Y12 inhibitor monotherapy was associated with a lower incidence of bleeding without increased risk of ischemic events compared with prolonged DAPT.TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02079194.PMID:38654565 | PMC:PMC11040264 | DOI:10.4070/kcj.2023.0268 (Source: Korean Circulation Journal)
Source: Korean Circulation Journal - April 24, 2024 Category: Cardiology Authors: Pil Sang Song Seok-Woo Seong Ji-Yeon Kim Soo Yeon An Mi Joo Kim Kye Taek Ahn Seon-Ah Jin Jin-Ok Jeong Jeong Hoon Yang Joo-Yong Hahn Hyeon-Cheol Gwon Woo Jin Jang Hyuck Jun Yoon Jang-Whan Bae Woong Gil Choi Young Bin Song Source Type: research
Gender perspective in the care experience and in the results of patients who consult for chest pain in an emergency department
CONCLUSIONS: Gender did not affect precordial pain care, diagnosis, and treatment times, highlighting the quality of hospital care.PMID:38653253 | DOI:10.24875/ACM.23000212 (Source: Archivos de Cardiologia de Mexico)
Source: Archivos de Cardiologia de Mexico - April 23, 2024 Category: Cardiology Authors: Mar ía F Grande-Ratti Mar ía C Llamedo Agustina B Pires Mar ía V Giuffre Brenda N Garrido Agustina Saldarini Pedro Touzas Bernardo Mart ínez Ignacio M Bluro Source Type: research
Gender perspective in the care experience and in the results of patients who consult for chest pain in an emergency department
CONCLUSIONS: Gender did not affect precordial pain care, diagnosis, and treatment times, highlighting the quality of hospital care.PMID:38653253 | DOI:10.24875/ACM.23000212 (Source: Archivos de Cardiologia de Mexico)
Source: Archivos de Cardiologia de Mexico - April 23, 2024 Category: Cardiology Authors: Mar ía F Grande-Ratti Mar ía C Llamedo Agustina B Pires Mar ía V Giuffre Brenda N Garrido Agustina Saldarini Pedro Touzas Bernardo Mart ínez Ignacio M Bluro Source Type: research
Gender perspective in the care experience and in the results of patients who consult for chest pain in an emergency department
CONCLUSIONS: Gender did not affect precordial pain care, diagnosis, and treatment times, highlighting the quality of hospital care.PMID:38653253 | DOI:10.24875/ACM.23000212 (Source: Archivos de Cardiologia de Mexico)
Source: Archivos de Cardiologia de Mexico - April 23, 2024 Category: Cardiology Authors: Mar ía F Grande-Ratti Mar ía C Llamedo Agustina B Pires Mar ía V Giuffre Brenda N Garrido Agustina Saldarini Pedro Touzas Bernardo Mart ínez Ignacio M Bluro Source Type: research
